- Market Realist•yesterday
Novartis (NVS) is set to release its 4Q16 earnings on January 25, 2017. Analysts estimate its 4Q16 earnings per share to be $1.12.
Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report fourth-quarter and full year 2016 results on Jan 25.
- Bloomberg•2 days ago
Joe Jimenez, Novartis chief executive officer, discusses the outlook for the pharmaceutical industry under President Donald Trump. He speaks with Bloomberg's Erik Schatzker at the World Economic Forum ...
NVS : Summary for Novartis AG Common Stock - Yahoo Finance
Novartis AG (NVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||70.30 - 70.79|
|52 Week Range||66.93 - 83.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||24.91|
|Dividend & Yield||2.72 (3.78%)|
|1y Target Est||N/A|